Wenshi M. Wang

Jiangsu Key Laboratory Of Immunity And Metabolism
Xuzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Viral entry defines the hepatitis E virus species barrier in murine hepatocytes.

Viral entry defines the hepatitis E virus species barrier in murine hepatocytes.

Journal: Emerging microbes & infections
Published: July 27, 2026

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study.

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study.

Journal: New microbes and new infections
Published: February 24, 2026

Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment.

Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment.

Journal: mBio
Published: February 05, 2026

Identification of G-Quadruplexes in Hepatitis E Virus Negative-Sense Genomic RNA as Potent Antiviral Targets.

Identification of G-Quadruplexes in Hepatitis E Virus Negative-Sense Genomic RNA as Potent Antiviral Targets.

Journal: ACS infectious diseases
Published: January 28, 2026

Comprehensive analysis of epidemiological and clinical features of Oropouche virus infection (1975 to 2025): a systematic review.

Comprehensive analysis of epidemiological and clinical features of Oropouche virus infection (1975 to 2025): a systematic review.

Journal: New microbes and new infections
Published: December 19, 2025

Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment.

Multimodal characterization of the responsiveness of eight hepatitis D virus genotype isolates to interferon-alpha treatment.

Journal: Journal of virology
Published: September 18, 2025

Status and outlook of mRNA therapeutics for viral diseases.

Status and outlook of mRNA therapeutics for viral diseases.

Journal: EMBO molecular medicine
Published: September 12, 2025

Phylogenomics and structural modelling feature accelerated evolution of Oropouche virus: 1955 to 2024.

Phylogenomics and structural modelling feature accelerated evolution of Oropouche virus: 1955 to 2024.

Journal: Virologica Sinica
Published: May 12, 2025

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses.

Journal: Communications biology
Published: April 14, 2025

Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery.

Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery.

Journal: Cell reports. Medicine
Published: February 15, 2025

Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket-Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target.

Hepatitis E Virus ORF1 Polyprotein Harbors a Pocket-Like Cavity That Is Vital for Virus Replication and Represents a Novel Antiviral Target.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 26, 2025

Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development.

Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development.

Journal: Nature communications
Published: November 16, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026